ATRX and neoplasm: Positive immunohistochemical staining for p53 was detected in 89% of the cases (31/35) and loss of ATRX nuclear staining in tumor cells was observed in 24% of the cases (8/34; one case was considered noninformative since there was not an appropriate internal positive control of adjacent nontumor cells).